A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide
Clinical trial NCT04497961 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04497961
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-28
- Primary completion
- 2026-08-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.